Clinical trial
Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or…
NCT00006021 · University of Miami, Other · Completed
Key facts
| NCT number | NCT00006021 |
|---|---|
| Title | Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma |
| Official title | Phase I/II Trial of Arsenic Trioxide (As2O3) With Ascorbic Acid in the Treatment of Relapsed/Refractory Multiple Myeloma |
| Lead sponsor | University of Miami, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Dietary Supplement, Drug |
| Interventions | ascorbic acid, arsenic trioxide |
| Enrollment | 22 |
| Start date | Jun 1, 2000 |
| Primary completion | May 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 15, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: